quinazolines has been researched along with Tuberculosis, Multidrug-Resistant in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacherjee, S; Krishnan, MY; Kumar, A; Kumari, N; Panda, G; Parwez, S; Siddiqi, MI; Venugopal, U | 1 |
| Benjak, A; Cole, ST; Foo, CS; Lamprecht, DA; Lupien, A; Makarov, VA; Monakhova, N; Pethe, K; Piton, J; Savina, S; Steyn, AJC; Vocat, A | 1 |
| Karpoormath, R; Palkar, M; Patel, HM | 1 |
3 other study(ies) available for quinazolines and Tuberculosis, Multidrug-Resistant
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of (Quinazoline 4-yloxy)acetamide and (4-oxoquinazoline-3(4H)-yl)acetamide derivatives as inhibitors of Mycobacterium tuberculosis bd oxidase.
Topics: Acetamides; Adenosine Triphosphate; Amides; Cytochromes; Electron Transport Complex IV; Humans; Mycobacterium tuberculosis; Oxidoreductases; Protons; Quinazolines; Tuberculosis, Multidrug-Resistant | 2022 |
New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Bacterial; Electron Transport Complex III; Humans; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Quinazolines; Tuberculosis, Multidrug-Resistant | 2020 |
Exploring MDR-TB Inhibitory Potential of 4-Aminoquinazolines as Mycobacterium tuberculosis N-Acetylglucosamine-1-Phosphate Uridyltransferase (GlmU
Topics: Antitubercular Agents; Enzyme Inhibitors; Mycobacterium tuberculosis; Nucleotidyltransferases; Quinazolines; Spectrum Analysis; Tuberculosis, Multidrug-Resistant | 2020 |